[Outcomes evaluation after the implementation of a pre-hospital thrombolysis protocol in rural areas]

Semergen. 2016 Oct;42(7):440-448. doi: 10.1016/j.semerg.2015.09.002. Epub 2015 Oct 17.
[Article in Spanish]

Abstract

Introduction: The aim is to evaluate the outcomes obtained from the implementation of a pre-hospital thrombolysis protocol in 3 rural emergency care teams, as well as delays and strategies of reperfusion applied in the treatment of the ST-segment elevation myocardial infarction.

Material and methods: Retrospective cohort study (n=52) with historical control (n=20) of the patients assisted for ST-segment elevation myocardial infarction. Medical emergency care teams, hospital, computerized medical history and ARIAM register reports were revised, obtaining epidemiological and clinical features, off-hospital management, reperfusion, time intervals and mortality.

Results: The baseline features in both groups were not significantly different. There was a non-significant improvement of emergency care teams-hospital diagnostic concordance (85.3 versus 76.9%). We found a similar use of nitroglycerin, morphine and aspirin; significant increase (P<0.0001) of clopidogrel/prasugrel (55 versus 90.4%) and enoxaparin/fondaparinux (35 versus 76.9%), as well as pre-hospital thrombolysis (5 versus 30,8%, P<0.03), that was applied within the first 2h to 71.4%, with a median door-needle of 40min, whereas in-hospital thrombolysis and primary angioplasty were performed after 3h from the symptoms onset (P<0.01). Delays are associated with the patient's own lateness (P<0.02). Pharmaco-invasive strategy increases (62.5 versus 84.6%) more than primary angioplasty (15 versus 17.3%), reducing in-hospital thrombolysis (35 versus 19.2%), all of them non-significant. Complications are similar and one-year mortality is reduced (P<0.67).

Conclusions: The protocol is effective, safe, and reliable. It reduces delays and improves pre-hospital attention. The pharmaco-invasive strategy is a valid option.

Keywords: Acute coronary syndrome; Fibrinolysis; Fibrinólisis; Síndrome coronario agudo; Terapia trombolítica; Thrombolytic therapy.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Clinical Protocols
  • Drug Administration Schedule
  • Emergency Medical Services / methods*
  • Female
  • Fibrinolytic Agents / administration & dosage*
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Rural Health Services*
  • ST Elevation Myocardial Infarction / diagnosis
  • ST Elevation Myocardial Infarction / drug therapy*
  • Spain
  • Time Factors
  • Treatment Outcome

Substances

  • Fibrinolytic Agents